Highest-materiality recent filing
Approved 2026 Equity Incentive Plan authorizing up to 1,100,000 shares of common stock for equity awards.
NHTC Q1 2026 revenue $9.2M, down 14% YoY; net loss $154k vs prior year income
Revenue $9.2M, down 6% from Q4 2025 and 14% from Q1 2025.
NHTC repurchases all Broady family shares (~25.5% of outstanding) for $5.9M
Repurchased 2,935,227 shares (25.5% of outstanding) from George K. Broady trusts for $2.00/share, total $5.9M cash.
Natural Health Trends Q4 revenue $9.7M, net loss $0.05/share; full year revenue down 7%
Q4 revenue $9.7M, down 10% YoY but up 3% sequentially; net loss $588K ($0.05 diluted EPS).
Natural Health Trends Q3 loss widens; revenue down 11%; plans restructuring, dividend cut
Revenue $9.5M (-11% YoY); net loss $0.04/diluted share vs breakeven prior year.
NHTC Q2 2025 revenue $9.8M (-6% YoY); net income $15K vs $173K; dividend $0.20
Revenue $9.8M, down 6% from $10.5M in Q2 2024.
On July 29, 2024, the Board of Directors of the Company, upon the recommendation of the Company's Nominating and Corporate Governance Committee, expanded the size of the Board of Directors to five (5) members and elected Lucy Nduati as a director to fill the newly created directorship.
Max materiality 0.80 · Median 0.55 · Most common event earnings